Opinion: People like me with bipolar disorder must help shape research and clinical care
Doctors have observed and treated bipolar disorder for thousands of years. Known throughout history by…
Category: advocacy
Opinion: Unseen battles: The harsh realities of veterans’ access to health care
I remember the day I left the military after six years of active-duty service. The…
STAT+: Takeda is fourth big company to leave BIO since December
WASHINGTON — Takeda Pharmaceuticals has left the biotechnology industry’s main lobbying group, the fourth departure…
Opinion: Medicaid should cover donor breast milk for vulnerable infants
Each day, more than 1,000 babies are born prematurely in America. Born before 37 weeks…
Opinion: Needed for reproductive justice and autonomy: women in design
Powerful groups of mostly men are making major decisions about biology and bodies they know…
Opinion: Congress: Protect patients and enact the Nuclear Medicine Clarification Act
If a preventable error that might cause harm occurs during medical care, should there be…
STAT+: BIO’s top lobbyist exits, signaling reorganization
WASHINGTON — The biotech industry’s largest trade group has parted ways with its top lobbyist,…
Opinion: The influential adverse childhood experiences questionnaire should ask about gun violence
The adverse childhood experience (ACE) questionnaire has become a critical part of public health. It…
The latest twist in John Green’s anti-tuberculosis story: working with governments
WASHINGTON — John Green, the popular novelist and YouTube star, gave the health care world…
Opinion: Lessons for scientists from the All of Us Research Program backlash
Scientists are taught early in our training that criticism is a fundamental part of the…
Opinion: Disabled scientists are often left out of academia. The NIH can help change that
Despite being the largest minority in the nation, disabled people like us have been structurally…
Opinion: Too many donor organs go to waste. Here’s how to get them into the patients who need them
As I was getting ready to perform a kidney transplant from a deceased donor on…
STAT+: San Diego biotech Neurocrine Biosciences joins PhRMA
WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying…
Colorado could cap payments for Amgen’s Enbrel
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Juul’s internal playbook opens a rare window into influence in Washington
WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker…
Gilead sours on the ‘don’t eat me’ business
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Health care negotiations on Capitol Hill are clear as mud
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Could private equity be the future of private practice? A new lobbying group thinks so
Private equity gets a bad rap in health care. But some doctors see that kind…
STAT+: HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy
WASHINGTON — He’s been called the “invisible” secretary. So far removed from the White House…
Opinion: Sen. Maggie Hassan on what Congress must do next to fight the opioid crisis
Few public health challenges have been more daunting and persistent than the opioid crisis, which…
At JPM, how much health policy talk should we expect?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Another major pharma company departs BIO
WASHINGTON — UCB left BIO at the end of 2023, the second major member company to…
Anavex’s slow journey to failure
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Being a chronically ill young adult is hard enough. Finding information about my fertility is even harder
I recently turned 25. I should be taking risks, jet-setting with other Barbies, and flouncing…
An ugly fight over care for the poor in Texas
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Remembering Betty Rollin, who told her breast surgeon that post-operative appearance mattered to her—and other women
Women who had undergone disfiguring surgery for breast cancer, according to one surgeon in the…
STAT+: AAFP’s CEO on how to keep primary care doctors in the field
In ten years, the United States could be short as many as 48,000 primary care…
Opinion: Alzheimer’s drug approvals show we need a reevaluation of patient advocacy
When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare…
Opinion: The WHO recognizes noma after years of medical-dental disconnect
Fidel Strub was 3 years old when his face began rotting away. “It’s hell. It’s…
Opinion: Sobering centers offer a safe place to recover from intoxication. Every community should have one
Every day, thousands of individuals across the United States call 911 due to concern about…
STAT+: UnitedHealth executive to head health insurance group AHIP
WASHINGTON — An executive at insurance giant UnitedHealth Group is slated to be the next…
Opinion: U.S. medical schools aren’t teaching future doctors about 7.4 million of their patients
Oliver McGowan was 18 years old when he was hospitalized in England with recurrent seizures…
Diabetes ‘epidemic’ gets a Senate hearing
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT Health News: Abortion ‘companion networks,’ NEJM’s racist past, and other stories you need to read
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
STAT+: BIO selects rare disease advocate, biotech executive John Crowley as new CEO
WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John…
Opinion: Big Weed today is a whole lot like Big Tobacco in the 1950s
OK, marijuana is now legal. So where’s the public health approach? Strictly speaking, marijuana use…
STAT+: Vertex pushes a donation program to widen access to cystic fibrosis treatments, but advocates say it’s not enough
Vertex Pharmaceuticals is being accused by a group of advocates and physicians of refusing to…
Opinion: What Rosalynn Carter understood about mental health
Few people leave the world with as much grace or influence as Rosalynn Smith Carter,…
Opinion: Ohio has enshrined the right to an abortion. But major obstacles remain for patients and providers
Last week those of us who work in reproductive health care celebrated a historic victory in Ohio:…
Opinion: Congress must reauthorize the National Advisory Committee for Seniors and Disasters
With the election of Rep. Mike Johnson as speaker of the House, the urgent and…
Medicare eligibility is tripping up the GOP presidential candidates
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Pulling probiotics from NICUs can put preemies at risk of necrotizing enterocolitis
Maybe probiotics would have saved my son’s life. I’ll never know because when I asked…
Opinion: Listen: Putting an end to a racist ‘diagnosis’
The term “excited delirium” has been used for years by law enforcement and other first…
Opinion: Many Americans receive too much health care. That may finally be changing
The opioid crisis rocked America, bringing addiction and overdose into the spotlight. But it also…
Opinion: There’s a real risk that harm reduction could be a fad
Harm reduction is having its moment in America. The doors of drug-related harm reduction have…
Opinion: Do celebrity vaccine endorsements like Travis Kelce’s actually change behavior?
Once the domain of aging TV stars, hawking health products from vitamins to diabetes supplies…
Opinion: I lost my son to OxyContin. ‘The Fall of the House of Usher’ is my Sackler revenge fantasy
Editor’s note: This essay contains spoilers for the Netflix show “The Fall of the House…
Opinion: The pink ribbon of breast cancer awareness needs a splash of blue for men
Everyone knows the universal symbol of breast cancer: the pink ribbon. Promoted by the Union…
Opinion: Insulin is increasingly affordable in the U.S. What about the rest of the world?
In March, Eli Lilly, Novo Nordisk, and Sanofi — the world’s three largest insulin manufacturers…
STAT+: Court strikes down Trump-era rule that allowed health insurers to broadly use copay accumulators
A U.S. judge has struck down a Trump administration rule that allowed health insurers not…